About this Journal Submit a Manuscript Table of Contents
Arthritis
Volume 2011 (2011), Article ID 683970, 16 pages
http://dx.doi.org/10.1155/2011/683970
Review Article

Developmental Mechanisms in Articular Cartilage Degradation in Osteoarthritis

Institute of Rheumatology, Russian Academy of Medical Sciences, Kashirskoye Shosse 34A, Moscow 115522, Russia

Received 5 August 2010; Accepted 9 December 2010

Academic Editor: Henning Bliddal

Copyright © 2011 Elena V. Tchetina. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Hunter and D. T. Felson, “Osteoarthritis,” British Medical Journal, vol. 332, no. 7542, pp. 639–642, 2006. View at Scopus
  2. S. B. Abramson and M. Attur, “Developments in the scientific understanding of osteoarthritis,” Arthritis Research & Therapy, vol. 11, no. 3, article 227, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. R. Poole, “Cartilage in health and disease,” in Arthritis and Allied Conditions: A Textbook of Rheumatology, W. Koopman, Ed., pp. 223–269, Lippincott, Williams & Wilkins, Philadelphia, Pa, USA, 15th edition, 2005.
  4. H. Nagase and M. Kashiwagi, “Aggrecanases and cartilage matrix degradation,” Arthritis Research & Therapy, vol. 5, no. 2, pp. 94–103, 2003. View at Scopus
  5. A. R. Poole, F. Nelson, L. Dahlberg et al., “Proteolysis of the collagen fibril in osteoarthritis,” Biochemical Society Symposium, no. 70, pp. 115–123, 2003. View at Scopus
  6. A. R. Poole, F. Guilak , and S. B. Abramson, “Etiopathogenesis of osteoarthritis,” in Osteoarthritis: Diagnosis and Medical/Surgical Management, R. W. Moskowitz, R. D. Altman, M. C. Hochberg, J. A. Buckwalter, and V. M. Goldberg, Eds., pp. 27–49, Williams & Wilkins, Lippincott, Pa, USA, 4th edition, 2007.
  7. A. R. Poole, M. Kobayashi, T. Yasuda et al., “Type II collagen degradation and its regulation in articular cartilage in osteoarthritis,” Annals of the Rheumatic Diseases, vol. 61, no. 2, pp. ii78–ii81, 2002. View at Scopus
  8. C. W. Wu, E. V. Tchetina, F. Mwale et al., “Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization,” Journal of Bone and Mineral Research, vol. 17, no. 4, pp. 639–651, 2002. View at Scopus
  9. R. C. Billinghurst, L. Dahlberg, M. Ionescu et al., “Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage,” Journal of Clinical Investigation, vol. 99, no. 7, pp. 1534–1545, 1997. View at Scopus
  10. L. Dahlberg, R. C. Billinghurst, G. Webb et al., “Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1),” Arthritis and Rheumatism, vol. 43, no. 3, pp. 673–682, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Aigner, J. Haag, J. Martin, and J. Buckwalter, “Osteoarthritis: aging of matrix and cells—going for a remedy,” Current Drug Targets, vol. 8, no. 2, pp. 325–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Aigner and N. Gerwin, “Growth plate cartilage as developmental model in osteoarthritis research potentials and limitations,” Current Drug Targets, vol. 8, no. 2, pp. 377–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. M. van der Kraan, E. N. Blaney Davidson, and W. B. van den Berg, “A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis,” Arthritis Research & Therapy, vol. 12, no. 1, pp. 201–214, 2010.
  14. D. M. Findlay, “Vascular pathology and osteoarthritis,” Rheumatology, vol. 46, no. 12, pp. 1763–1768, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. P. Ghosh and P. A. Cheras, “Vascular mechanisms in osteoarthritis,” Best Practice and Research: Clinical Rheumatology, vol. 15, no. 5, pp. 693–709, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. H. de Jong, S. E. Berlo, P. Hombrink et al., “Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 255–262, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. L. I. Sakkas and C. D. Platsoucas, “The role of T cells in the pathogenesis of osteoarthritis,” Arthritis and Rheumatism, vol. 56, no. 2, pp. 409–424, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. C. J. Malemud, “Anticytokine therapy for osteoarthritis: evidence to date,” Drugs and Aging, vol. 27, no. 2, pp. 95–115, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. Kobayashi, G. R. Squires, A. Mousa et al., “Role of interleukin-1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage,” Arthritis and Rheumatism, vol. 52, no. 1, pp. 128–135, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. C. B. Little and A. J. Fosang, “Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis—insights from studies of aggrecan and collagen proteolysis?” Current Drug Targets, vol. 11, no. 5, pp. 561–575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. F. Loeser, “Molecular mechanisms of cartilage destruction in osteoarthritis,” Journal of Musculoskeletal Neuronal Interactions, vol. 8, no. 4, pp. 303–306, 2008. View at Scopus
  22. E. V. Tchetina, G. Squires, and A. R. Poole, “Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions,” Journal of Rheumatology, vol. 32, no. 5, pp. 876–886, 2005. View at Scopus
  23. R. Yagi, D. McBurney, D. Laverty, S. Weiner, and W. E. Horton Jr., “Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype,” Journal of Orthopaedic Research, vol. 23, no. 5, pp. 1128–1138, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. R. Terkeltaub, M. Lotz, K. Johnson et al., “Parathyroid hormone-related protein is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor β in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate,” Arthritis and Rheumatism, vol. 41, no. 12, pp. 2152–2164, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. K. von der Mark, T. Kirsch, A. Nerlich et al., “Type X collagen synthesis in human osteoarthritic cartilage: indication of chondrocyte hypertrophy,” Arthritis and Rheumatism, vol. 35, no. 7, pp. 806–811, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Girkontaite, S. Frischholz, P. Lammi et al., “Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies,” Matrix Biology, vol. 15, no. 4, pp. 231–238, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. G. D. Walker, M. Fischer, J. Gannon, R. C. Thompson, and T. R. Oegema, “Expression of type-X collagen in osteoarthritis,” Journal of Orthopaedic Research, vol. 13, no. 1, pp. 4–12, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. T. Kirsch, B. Swoboda, and H. D. Nah, “Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage,” Osteoarthritis and Cartilage, vol. 8, no. 4, pp. 294–302, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. D. Pfander, T. Cramer, E. Schipani, and R. S. Johnson, “HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes,” Journal of Cell Science, vol. 116, no. 9, pp. 1819–1826, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Pullig, G. Weseloh, D. L. Ronneberger, S. M. Käkönen, and B. Swoboda, “Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone,” Calcified Tissue International, vol. 67, no. 3, pp. 230–240, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. G. A. Karpouzas and R. A. Terkeltaub, “New developments in the pathogenesis of articular cartilage calcification,” Current Rheumatology Reports, vol. 1, no. 2, pp. 121–127, 1999. View at Scopus
  32. K. Johnson and R. Terkeltaub, “Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess,” Osteoarthritis and Cartilage, vol. 12, no. 4, pp. 321–335, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. F. J. Blanco, R. Guitian, E. Vázquez-Martul, F. J. de Toro, and F. Galdo, “Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology,” Arthritis and Rheumatism, vol. 41, no. 2, pp. 284–289, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Robertson, A. T. Pennock, F. L. Harwood, A. C. Pomerleau, R. T. Allen, and D. Amiel, “Characterization of pro-apoptotic and matrix-degradative gene expression following induction of osteoarthritis in mature and aged rabbits,” Osteoarthritis and Cartilage, vol. 14, no. 5, pp. 471–476, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. E. Tchetina, F. Mwale, and A. R. Poole, “Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation,” Journal of Bone and Mineral Research, vol. 18, no. 5, pp. 844–851, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. V. Ham and D. H. Cormack, Ham's Histology, Lippincott, Philadelphia, Pa, USA, 1987.
  37. S. Yamane, E. Cheng, Z. You, and A. H. Reddi, “Gene expression profiling of mouse articular and growth plate cartilage,” Tissue Engineering, vol. 13, no. 9, pp. 2163–2173, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. P. Krejci, D. Krakow, P. B. Mekikian, and W. R. Wilcox, “Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage,” Pediatric Research, vol. 61, no. 3, pp. 267–272, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. O. Nilsson, E. A. Parker, A. Hegde, M. Chau, K. M. Barnes, and J. Baron, “Gradients in bone morphogenetic protein-related gene expression across the growth plate,” Journal of Endocrinology, vol. 193, no. 1, pp. 75–84, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. H. C. Anderson, P. T. Hodges, X. M. Aguilera, L. Missana, and P. E. Moylan, “Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage,” Journal of Histochemistry and Cytochemistry, vol. 48, no. 11, pp. 1493–1502, 2000. View at Scopus
  41. S. Matsunaga, T. Yamamoto, and K. Fukumura, “Temporal and spatial expressions of transforming growth factor-βs and their receptors in epiphyseal growth plate,” International Journal of Oncology, vol. 14, no. 6, pp. 1063–1067, 1999. View at Scopus
  42. T. A. Damron, S. Mathur, J. A. Horton et al., “Temporal changes in PTHrP, Bcl-2, Bax, caspase, TGF-β, and FGF-2 expression following growth plate irradiation with or without radioprotectant,” Journal of Histochemistry and Cytochemistry, vol. 52, no. 2, pp. 157–167, 2004. View at Scopus
  43. M. P. Verdier, S. Seité, K. Guntzer, J. P. Pujol, and K. Boumédiène, “Immunohistochemical analysis of transforming growth factor beta isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads,” Rheumatology International, vol. 25, no. 2, pp. 118–124, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. F. Beier, Z. Ali, D. Mok et al., “TGFβ and PTHrP control chondrocyte proliferation by activating cyclin D1 expression,” Molecular Biology of the Cell, vol. 12, no. 12, pp. 3852–3863, 2001. View at Scopus
  45. H. I. Roach, G. Mehta, R. O. C. Oreffo, N. M. P. Clarke, and C. Cooper, “Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physis,” Journal of Histochemistry and Cytochemistry, vol. 51, no. 3, pp. 373–383, 2003. View at Scopus
  46. F. Mwale, C. Billinghurst, W. Wu et al., “Selective assembly and remodelling of collagens II and IX associated with expression of the chondrocyte hypertrophic phenotype,” Developmental Dynamics, vol. 218, no. 4, pp. 648–662, 2000. View at Scopus
  47. L. A. Neuhold, L. Killar, W. Zhao et al., “Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 35–44, 2001. View at Scopus
  48. A. L. Armstrong, H. J. Barrach, and M. G. Ehrlich, “Identification of the metalloproteinase stromelysin in the physis,” Journal of Orthopaedic Research, vol. 20, no. 2, pp. 289–294, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. F. H. Wezeman and M. R. Bollnow, “Immunohistochemical localization of fibroblast growth factor-2 in normal and brachymorphic mouse tibial growth plate and articular cartilage,” Histochemical Journal, vol. 29, no. 6, pp. 505–514, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Horner, P. Kemp, C. Summers et al., “Expression and distribution of transforming growth factor-β isoforms and their signaling receptors in growing human bone,” Bone, vol. 23, no. 2, pp. 95–102, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Wang, S. Nishida, T. Sakata et al., “Insulin-like growth factor-I is essential for embryonic bone development,” Endocrinology, vol. 147, no. 10, pp. 4753–4761, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. P. de los Rios and D. J. Hill, “Cellular localization and expression of insulin-like growth factors (IGFS) and IGF binding proteins within the epiphyseal growth plate of the ovine fetus: possible functional implications,” Canadian Journal of Physiology and Pharmacology, vol. 77, no. 4, pp. 235–249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. D. M. Shinar, N. Endo, D. Halperin, G. A. Rodan, and M. Weinreb, “Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone,” Endocrinology, vol. 132, no. 3, pp. 1158–1167, 1993. View at Publisher · View at Google Scholar · View at Scopus
  54. Q. Ma, X. Li, D. Vale-Cruz, M. L. Brown, F. Beier, and P. LuValle, “Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes,” Journal of Cellular Biochemistry, vol. 101, no. 2, pp. 477–487, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. H. Akiyama, M. C. Chaboissier, J. F. Martin, A. Schedl, and B. de Crombrugghe, “The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6,” Genes and Development, vol. 16, no. 21, pp. 2813–2828, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. D. W. Burton, M. Foster, K. A. Johnson, M. Hiramoto, L. J. Deftos, and R. Terkeltaub, “Chondrocyte calcium-sensing receptor expression is up-regulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression,” Osteoarthritis Cartilage, vol. 13, no. 5, pp. 395–404, 2005.
  57. J. A. Uría, M. Balbín, J. M. López et al., “Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor,” American Journal of Pathology, vol. 153, no. 1, pp. 91–101, 1998. View at Scopus
  58. P. Borden, D. Solymar, A. Sucharczuk, B. Lindman, P. Cannon, and R. A. Heller, “Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes,” Journal of Biological Chemistry, vol. 271, no. 38, pp. 23577–23581, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Haeusler, I. Walter, M. Helmreich, and M. Egerbacher, “Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation,” Calcified Tissue International, vol. 76, no. 5, pp. 326–335, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. C. Li, L. Chen, T. Iwata, M. Kitagawa, X. Y. Fu, and C. X. Deng, “A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors,” Human Molecular Genetics, vol. 8, no. 1, pp. 35–44, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Tsuchimochi, M. Otero, C. L. Dragomir et al., “GADD45β enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPβ-TAD4 in terminally differentiating chondrocytes,” Journal of Biological Chemistry, vol. 285, no. 11, pp. 8395–8407, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. K. Ijiri, L. F. Zerbini, H. Peng et al., “A novel role for GADD45β as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation,” Journal of Biological Chemistry, vol. 280, no. 46, pp. 38544–38555, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. M. D. Kinkel, R. Yagi, D. McBurney, A. Nugent, and W. E. Horton Jr., “Age-related expression patterns of Bag-1 and Bcl-2 in growth plate and articular chondrocytes,” Anatomical Record Part A, vol. 279, no. 2, pp. 720–728, 2004. View at Scopus
  64. J. P. Tuckermann, K. Pittois, N. C. Partridge, J. Merregaert, and P. Angel, “Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation: sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse,” Journal of Bone and Mineral Research, vol. 15, no. 7, pp. 1257–1265, 2000. View at Scopus
  65. F. M. D. Henson, M. E. Davies, J. N. Skepper, and L. B. Jeffcott, “Localisation of alkaline phosphatase in equine growth cartilage,” Journal of Anatomy, vol. 187, no. 1, pp. 151–159, 1995. View at Scopus
  66. R. Pogue and K. Lyons, “BMP signaling in the cartilage growth plate,” Current Topics in Developmental Biology, vol. 76, pp. 1–48, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. Y. Wang, F. Middleton, J. A. Horton, L. Reichel, C. E. Farnum, and T. A. Damron, “Microarray analysis of proliferative and hypertrophic growth plate zones identifies differentiation markers and signal pathways,” Bone, vol. 35, no. 6, pp. 1273–1293, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. T. Sakou, T. Onishi, T. Yamamoto, T. Nagamine, T. K. Sampath, and P. Ten Dijke, “Localization of Smads, the TGF-β family intracellular signaling components during endochondral ossification,” Journal of Bone and Mineral Research, vol. 14, no. 7, pp. 1145–1152, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. T. Fukunaga, T. Yamashiro, S. Oya, N. Takeshita, M. Takigawa, and T. Takano-Yamamoto, “Connective tissue growth factor mRNA expression pattern in cartilages is associated with their type I collagen expression,” Bone, vol. 33, no. 6, pp. 911–918, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Álvarez, L. Costales, R. Serra, M. Balbín, and J. M. López, “Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossification,” Journal of Bone and Mineral Research, vol. 20, no. 6, pp. 1011–1021, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. H. E. MacLean and H. M. Kronenberg, “Localization of Indian hedgehog and PTH/PTHrP receptor expression in relation to chondrocyte proliferation during mouse bone development,” Development Growth and Differentiation, vol. 47, no. 2, pp. 59–63, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. J. M. Kindblom, O. Nilsson, T. Hurme, C. Ohlsson, and L. Sävendahl, “Expression and localization of Indian hedgehog (Ihh) and parathyroid hormone related protein (PTHrP) in the human growth plate during pubertal development,” Journal of Endocrinology, vol. 174, no. 2, pp. R1–R6, 2002. View at Scopus
  73. F. Yamashita, K. Sakakida, K. Kusuzaki, H. Takeshita, and A. Kuzuhara, “Immunohistochemical localization of interleukin 1 in human growth cartilage,” Nippon Seikeigeka Gakkai Zasshi, vol. 63, no. 5, pp. 562–568, 1989.
  74. P. Ducy, R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty, “Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation,” Cell, vol. 89, no. 5, pp. 747–754, 1997.
  75. P. M. van der Kraan, E. N. Blaney Davidson, A. Blom, and W. B. van den Berg, “TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis. Modulation and integration of signaling pathways through receptor-Smads,” Osteoarthritis and Cartilage, vol. 17, no. 12, pp. 1539–1545, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. T. Komori, “A fundamental transcription factor for bone and cartilage,” Biochemical and Biophysical Research Communications, vol. 276, no. 3, pp. 813–816, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. S. Takeda, J. P. Bonnamy, M. J. Owen, P. Ducy, and G. Karsenty, “Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice,” Genes and Development, vol. 15, no. 4, pp. 467–481, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. C. Ueta, M. Iwamoto, N. Kanatani et al., “Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes,” Journal of Cell Biology, vol. 153, no. 1, pp. 87–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. D. Porte, J. Tuckermann, M. Becker et al., “Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone,” Oncogene, vol. 18, no. 3, pp. 667–678, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. M. J. G. Jiménez, M. Balbín, J. M. López, J. Alvarez, T. Komori, and C. López-Otín, “Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation,” Molecular and Cellular Biology, vol. 19, no. 6, pp. 4431–4442, 1999. View at Scopus
  81. F. Mwale, E. Tchetina, C. W. Wu, and A. R. Poole, “The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: an in situ study of collagens II and IX and proteoglycan,” Journal of Bone and Mineral Research, vol. 17, no. 2, pp. 275–283, 2002. View at Scopus
  82. W. Wang, J. Xu, B. Du, and T. Kirsch, “Role of the progressive ankylosis gene (ank) in cartilage mineralization,” Molecular and Cellular Biology, vol. 25, no. 1, pp. 312–323, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. W. Wang, J. Xu, and T. Kirsch, “Annexin-mediated Ca2+ influx regulates growth plate chondrocyte maturation and apoptosis,” Journal of Biological Chemistry, vol. 278, no. 6, pp. 3762–3769, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. T. Kirsch, “Annexins—their role in cartilage mineralization,” Frontiers in Bioscience, vol. 10, pp. 576–581, 2005. View at Scopus
  85. W. Wang, J. Xu, and T. Kirsch, “Annexin V and terminal differentiation of growth plate chondrocytes,” Experimental Cell Research, vol. 305, no. 1, pp. 156–165, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. R. K. Gill, R. T. Turner, T. J. Wronski, and N. H. Bell, “Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor β in rat bone, and reduction is prevented by testosterone,” Endocrinology, vol. 139, no. 2, pp. 546–550, 1998. View at Publisher · View at Google Scholar · View at Scopus
  87. I. M. Shapiro, C. S. Adams, T. Freeman, and V. Srinivas, “Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate,” Birth Defects Research Part C, vol. 75, no. 4, pp. 330–339, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. R. C. Olney, J. Wang, J. E. Sylvester, and E. B. Mougey, “Growth factor regulation of human growth plate chondrocyte proliferation in vitro,” Biochemical and Biophysical Research Communications, vol. 317, no. 4, pp. 1171–1182, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. M. R. Hutchison, M. H. Bassett, and P. C. White, “Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation,” Endocrinology, vol. 148, no. 7, pp. 3122–3130, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. H. M. Kronenberg, “PTHrP and skeletal development,” Annals of the New York Academy of Sciences, vol. 1068, no. 1, pp. 1–13, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. T. F. Li, Y. Dong, A. M. Ionescu et al., “Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway,” Experimental Cell Research, vol. 299, no. 1, pp. 128–136, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. Y. F. Dong, Y. Soung do, E. M. Schwarz, R. J. O'Keefe, and H. Drissi, “Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor,” Journal of Cellular Physiology, vol. 208, no. 1, pp. 77–86, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. D. Kiepe, S. Ciarmatori, A. Haarmann, and B. Tönshoff, “Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5,” American Journal of Physiology, vol. 290, no. 2, pp. E363–E371, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. A. C. Karaplis, A. Luz, J. Glowacki et al., “Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene,” Genes and Development, vol. 8, no. 3, pp. 277–289, 1994. View at Scopus
  95. N. Amizuka, H. Warshawsky, J. E. Henderson, D. Goltzman, and A. C. Karaplis, “Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation,” Journal of Cell Biology, vol. 126, no. 6, pp. 1611–1623, 1994. View at Scopus
  96. E. C. Weir, W. M. Philbrick, M. Amling, L. A. Neff, R. Baron, and A. E. Broadus, “Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 19, pp. 10240–10245, 1996. View at Publisher · View at Google Scholar · View at Scopus
  97. B. Lanske, A. C. Karaplis, K. Lee et al., “PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth,” Science, vol. 273, no. 5275, pp. 663–666, 1996. View at Scopus
  98. A. Vortkamp, K. Lee, B. Lanske, G. V. Segre, H. M. Kronenberg, and C. J. Tabin, “Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein,” Science, vol. 273, no. 5275, pp. 613–622, 1996. View at Scopus
  99. E. Yoshida, M. Noshiro, T. Kawamoto, S. Tsutsumi, Y. Kuruta, and Y. Kato, “Direct inhibition of Indian hedgehog expression by parathyroid hormone (PTH)/PTH-related peptide and up-regulation by retinoic acid in growth plate chondrocyte cultures,” Experimental Cell Research, vol. 265, no. 1, pp. 64–72, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. B. St-Jacques, M. Hammerschmidt, and A. P. McMahon, “Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation,” Genes and Development, vol. 13, no. 16, pp. 2072–2086, 1999. View at Scopus
  101. M. Pacifici, T. Shimo, C. Gentili et al., “Syndecan-3: a cell-surface heparan sulfate proteoglycan important for chondrocyte proliferation and function during limb skeletogenesis,” Journal of Bone and Mineral Metabolism, vol. 23, no. 3, pp. 191–199, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. A. B. Roberts and M. B. Sporn, “Physiological actions and clinical applications of transforming growth factor-β (TGF-β),” Growth Factors, vol. 8, no. 1, pp. 1–9, 1993. View at Scopus
  103. G. Gibson, “Active role of chondrocyte apoptosis in endochondral ossification,” Microscopy Research and Technique, vol. 43, no. 2, pp. 191–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  104. X. Yang, L. Chen, X. Xu, C. Li, C. Huang, and C. X. Deng, “TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage,” Journal of Cell Biology, vol. 153, no. 1, pp. 35–46, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. R. Serra, A. Karaplis, and P. Sohn, “Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor β (TGF-β)on endochondral bone formation,” Journal of Cell Biology, vol. 145, no. 4, pp. 783–794, 1999. View at Publisher · View at Google Scholar · View at Scopus
  106. C. M. Ferguson, E. M. Schwarz, P. R. Reynolds, J. E. Puzas, R. N. Rosier, and R. J. O'Keefe, “Smad2 and 3 mediate transforming growth factor-β1-induced inhibition of chondrocyte maturation,” Endocrinology, vol. 141, no. 12, pp. 4728–4735, 2000. View at Publisher · View at Google Scholar
  107. R. T. Ballock, A. Heydemann, L. M. Wakefield, K. C. Flanders, A. B. Roberts, and M. B. Sporn, “TGF-β1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases,” Developmental Biology, vol. 158, no. 2, pp. 414–429, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. K. Bohme, K. H. Winterhhlter, and P. Bruckner, “Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by transforming growth factor-β2 and basic fibroblast growth factor in synergy,” Experimental Cell Research, vol. 216, no. 1, pp. 191–198, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. R. A. Terkeltaub, K. Johnson, D. Rohnow, R. Goomer, D. Burton, and L. J. Deftos, “Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells),” Journal of Bone and Mineral Research, vol. 13, no. 6, pp. 931–941, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. D. B. Pateder, R. N. Rosier, E. M. Schwarz et al., “PTHrP expression in chondrocytes, regulation by TGF-β, and interactions between epiphyseal and growth plate chondrocytes,” Experimental Cell Research, vol. 256, no. 2, pp. 555–562, 2000. View at Publisher · View at Google Scholar · View at PubMed
  111. H. Nagai and M. Aoki, “Inhibition of growth plate angiogenesis and endochondral ossification with diminished expression of MMP-13 in hypertrophic chondrocytes in FGF-2-treated rats,” Journal of Bone and Mineral Metabolism, vol. 20, no. 3, pp. 142–147, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. V. Szuts, U. Möllers, K. Bittner et al., “Terminal differentiation of chondrocytes is arrested at distinct stages identified by their expression repertoire of marker genes,” Matrix Biology, vol. 17, no. 6, pp. 435–448, 1998. View at Publisher · View at Google Scholar · View at Scopus
  113. Q. Wang, X. Wei, T. Zhu et al., “Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2,” Journal of Biological Chemistry, vol. 282, no. 14, pp. 10742–10748, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. T. Kobayashi, K. M. Lyons, A. P. McMahon, and H. M. Kronenberg, “BMP signaling stimulates cellular differentiation at multiple steps during cartilage development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18023–18027, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. B. S. Yoon, R. Pogue, D. A. Ovchinnikov et al., “BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways,” Development, vol. 133, no. 23, pp. 4667–4678, 2006. View at Publisher · View at Google Scholar · View at PubMed
  116. M. C. Stewart, R. M. Kadlcek, P. D. Robbins, J. N. Macleod, and R. T. Ballock, “Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation,” Journal of Bone and Mineral Research, vol. 19, no. 1, pp. 123–132, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  117. D. Zhang, E. M. Schwarz, R. N. Rosier, M. J. Zuscik, J. E. Puzas, and R. J. O'Keefe, “ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development,” Journal of Bone and Mineral Research, vol. 18, no. 9, pp. 1593–1604, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  118. C. D. Grimsrud, P. R. Romano, M. D'Souza et al., “BMP-6 is an autocrine stimulator of chondrocyte differentiation,” Journal of Bone and Mineral Research, vol. 14, no. 4, pp. 475–482, 1999. View at Scopus
  119. T. Takahashi, E. A. Morris, and S. B. Trippel, “Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes,” International Journal of Molecular Medicine, vol. 20, no. 1, pp. 53–57, 2007.
  120. G. Mailhot, M. Yang, A. Mason-Savas, C. A. Mackay, I. Leav, and P. R. Odgren, “BMP-5 expression increases during chondrocyte differentiation in vivo and in vitro and promotes proliferation and cartilage matrix synthesis in primary chondrocyte cultures,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 56–64, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. Z. Laron, “Insulin-like growth factor 1 (IGF-1): a growth hormone,” Molecular Pathology, vol. 54, no. 5, pp. 311–316, 2001. View at Publisher · View at Google Scholar · View at Scopus
  122. W. Hui, A. D. Rowan, and T. Cawston, “Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1α,” Annals of the Rheumatic Diseases, vol. 60, no. 3, pp. 254–261, 2001. View at Publisher · View at Google Scholar
  123. V. Lefebvre and P. Smits, “Transcriptional control of chondrocyte fate and differentiation,” Birth Defects Research Part C, vol. 75, no. 3, pp. 200–212, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. T. Hattori, C. Müller, S. Gebhard et al., “SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification,” Development, vol. 137, no. 6, pp. 901–911, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  125. M. Wuelling and A. Vortkamp, “Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification,” Pediatric Nephrology, vol. 25, no. 4, pp. 625–631, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. Q. Zhao, H. Eberspaecher, V. Lefebvre, and B. de Crombrugghe, “Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis,” Developmental Dynamics, vol. 209, no. 4, pp. 377–386, 1997. View at Publisher · View at Google Scholar · View at Scopus
  127. B. de Crombrugghe, V. Lefebvre, R. R. Behringer, W. Bi, S. Murakami, and W. Huang, “Transcriptional mechanisms of chondrocyte differentiation,” Matrix Biology, vol. 19, no. 5, pp. 389–394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  128. L. J. Ng, S. Wheatley, G. E. O. Muscat et al., “SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse,” Developmental Biology, vol. 183, no. 1, pp. 108–121, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. W. Bi, W. Huang, D. J. Whitworth et al., “Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6698–6703, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. S. Reppe, E. Rian, R. Jemtland, O. K. Olstad, V. T. Gautvik, and K. M. Gautvik, “Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like cells,” Journal of Bone and Mineral Research, vol. 15, no. 12, pp. 2402–2412, 2000. View at Scopus
  131. Y. Soung do, Y. Dong, Y. Wang et al., “Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation,” Journal of Bone and Mineral Research, vol. 22, no. 8, pp. 1260–1270, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  132. L. A. Solomon, N. G. Bérubé, and F. Beier, “Transcriptional regulators of chondrocyte hypertrophy,” Birth Defects Research Part C, vol. 84, no. 2, pp. 123–130, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. H. Drissi, M. Zuscik, R. Rosier, and R. O'Keefe, “Transcriptional regulation of chondrocyte maturation: potential involvement of transcription factors in OA pathogenesis,” Molecular Aspects of Medicine, vol. 26, no. 3, pp. 169–179, 2005. View at Publisher · View at Google Scholar · View at PubMed
  134. T. F. Li, M. J. Zuscik, A. M. Ionescu et al., “PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling,” Experimental Cell Research, vol. 300, no. 1, pp. 159–169, 2004. View at Publisher · View at Google Scholar · View at PubMed
  135. X. Zhang, N. Ziran, J. J. Goater et al., “Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-β delays hypertrophy and PGE2 inhibits terminal differentiation,” Bone, vol. 34, no. 5, pp. 809–817, 2004. View at Publisher · View at Google Scholar · View at PubMed
  136. Z. Schwartz, R. M. Gilley, V. L. Sylvia, D. D. Dean, and B. D. Boyan, “The effect of prostaglandin E2 on costochondral chondrocyte differentiation is mediated by cyclic adenosine 3',5'-monophosphate and protein kinase C,” Endocrinology, vol. 139, no. 4, pp. 1825–1834, 1998.
  137. C. Brochhausen, P. Neuland, C. J. Kirkpatrick, R. M. Nüsing, and G. Klaus, “Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ—prostaglandin E2 dependent proliferation of growth plate chondrocytes,” Arthritis Research & Therapy, vol. 8, no. 3, article R78, 2006. View at Publisher · View at Google Scholar · View at PubMed
  138. L. Wei, K. Kanbe, M. Lee et al., “Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation,” Developmental Biology, vol. 341, no. 1, pp. 236–245, 2010. View at Publisher · View at Google Scholar · View at PubMed
  139. W. Wang and T. Kirsch, “Annexin V/β5 integrin interactions regulate apoptosis of growth plate chondrocytes,” Journal of Biological Chemistry, vol. 281, no. 41, pp. 30848–30856, 2006. View at Publisher · View at Google Scholar · View at PubMed
  140. M. S. Domowicz, M. Cortes, J. G. Henry, and N. B. Schwartz, “Aggrecan modulation of growth plate morphogenesis,” Developmental Biology, vol. 329, no. 2, pp. 242–257, 2009. View at Publisher · View at Google Scholar · View at PubMed
  141. L. van der Weyden, L. Wei, J. Luo et al., “Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis,” American Journal of Pathology, vol. 169, no. 2, pp. 515–527, 2006. View at Publisher · View at Google Scholar
  142. O. Barbieri, S. Astigiano, M. Morini et al., “Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation,” American Journal of Physiology, vol. 285, no. 6, pp. C1504–C1512, 2003.
  143. R. M. Borzi., E. Olivotto, S. Pagani et al., “Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors,” Arthritis and Rheumatism, vol. 62, no. 8, pp. 2370–2381, 2010. View at Publisher · View at Google Scholar · View at PubMed
  144. C. J. Malemud, “Matrix metalloproteinases: role in skeletal development and growth plate disorders,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1702–1715, 2006.
  145. Q. Chen, D. M. Johnson, D. R. Haudenschild, and P. F. Goetinck, “Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation,” Developmental Biology, vol. 172, no. 1, pp. 293–306, 1995. View at Publisher · View at Google Scholar · View at PubMed
  146. J. A. Buckwalter and H. J. Mankin, “Articular cartilage repair and transplantation,” Arthritis and Rheumatism, vol. 41, no. 8, pp. 1331–1342, 1998. View at Publisher · View at Google Scholar
  147. T. E. Hardingham, A. J. Fosang, and J. Dudhia, “Aggrecan, the chondroitin sulfate/keratan sulfate proteoglycan from cartilage,” in Articular Cartilage and Osteoarthritis, K. Kuettner, et al., Ed., Raven Press, New York, NY, USA, 1992.
  148. T. Aigner, A. Zien, D. Hanisch, and R. Zimmer, “Gene expression in chondrocytes assessed with use of microarrays,” Journal of Bone and Joint Surgery. American, vol. 85, no. 1, pp. 117–123, 2003.
  149. L. C. Tetlow, D. J. Adlam, and D. E. Woolley, “Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes,” Arthritis and Rheumatism, vol. 44, no. 3, pp. 585–594, 2001. View at Publisher · View at Google Scholar
  150. W. B. van den Berg, “Growth factors in experimental osteoarthritis: transforming growth factor β pathogenic?” Journal of Rheumatology, vol. 22, no. 43, pp. 143–145, 1995.
  151. X. Chen, C. M. Macica, A. Nasiri, and A. E. Broadus, “Regulation of articular chondrocyte proliferation and differentiation by Indian hedgehog and parathyroid hormone-related protein in mice,” Arthritis and Rheumatism, vol. 58, no. 12, pp. 3788–3797, 2008. View at Publisher · View at Google Scholar · View at PubMed
  152. Y. Hiraki, H. Inoue, K. I. Iyama et al., “Identification of chondromodulin I as a novel endothelial cell growth inhibitor: purification and its localization in the avascular zone of epiphyseal cartilage,” Journal of Biological Chemistry, vol. 272, no. 51, pp. 32419–32426, 1997. View at Publisher · View at Google Scholar
  153. H. Kitahara, T. Hayami, K. Tokunaga et al., “Chondromodulin-I expression in rat articular cartilage,” Archives of Histology and Cytology, vol. 66, no. 3, pp. 221–228, 2003. View at Publisher · View at Google Scholar
  154. K. Ijiri, L. F. Zerbini, H. Peng et al., “Differential expression of GADD45β in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes,” Arthritis and Rheumatism, vol. 58, no. 7, pp. 2075–2087, 2008. View at Publisher · View at Google Scholar · View at PubMed
  155. H. W. Zhou, S. Q. Lou, and K. Zhang, “Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro,” Rheumatology, vol. 43, pp. 555–568, 2004.
  156. T. Aigner and L. McKenna, “Molecular pathology and pathobiology of osteoarthritic cartilage,” Cellular and Molecular Life Sciences, vol. 59, no. 1, pp. 5–18, 2002. View at Publisher · View at Google Scholar
  157. A. R. Poole, “What type of cartilage repair are we attempting to attain?” Journal of Bone and Joint Surgery. American, vol. 85, no. 1, pp. 40–44, 2003.
  158. A. Scharstuhl, H. L. Glansbeek, H. M. van Beuningen, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg, “Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair,” Journal of Immunology, vol. 169, no. 1, pp. 507–514, 2002.
  159. P. K. Bos, G. J. V. M. van Osch, D. A. Frenz, J. A. N. Verhaar, and H. L. Verwoerd-Verhoef, “Growth factor expression in cartilage wound healing: temporal and spatial immunolocalization in a rabbit auricular cartilage wound model,” Osteoarthritis and Cartilage, vol. 9, no. 4, pp. 382–389, 2001. View at Publisher · View at Google Scholar · View at PubMed
  160. A. H. White, R. E. B. Watson, B. Newman, A. J. Freemont, and G. A. Wallis, “Annexin VIII is differentially expressed by chondrocytes in the mammalian growth plate during endochondral ossification and in osteoarthritic cartilage,” Journal of Bone and Mineral Research, vol. 17, no. 10, pp. 1851–1858, 2002.
  161. G. E. Kempson, H. Muir, C. Pollard, and M. Tuke, “The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans,” Biochimica et Biophysica Acta, vol. 297, no. 2, pp. 456–472, 1973.
  162. A. R. Poole, L. C. Rosenberg, A. Reiner, M. Ionescu, E. Bogoch, and P. J. Roughley, “Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage,” Journal of Orthopaedic Research, vol. 14, no. 5, pp. 681–689, 1996. View at Publisher · View at Google Scholar · View at PubMed
  163. D. Pfander, B. Swoboda, and T. Kirsch, “Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes,” American Journal of Pathology, vol. 159, no. 5, pp. 1777–1783, 2001.
  164. W. Wu, R. C. Billinghurst, I. Pidoux et al., “Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13,” Arthritis and Rheumatism, vol. 46, no. 8, pp. 2087–2094, 2002. View at Publisher · View at Google Scholar · View at PubMed
  165. J. Quintavalla, C. Kumar, S. Daouti, E. Slosberg, and S. Uziel-Fusi, “Chondrocyte cluster formation in agarose cultures as a functional assay to identify genes expressed in osteoarthritis,” Journal of Cellular Physiology, vol. 204, no. 2, pp. 560–566, 2005. View at Publisher · View at Google Scholar · View at PubMed
  166. A. Maroudas, M. T. Bayliss, and M. F. Venn, “Further studies on the composition of human femoral head cartilage,” Annals of the Rheumatic Diseases, vol. 39, no. 5, pp. 514–523, 1980.
  167. S. A. Semevolos, M. L. Strassheim, J. L. Haupt, and A. J. Nixon, “Expression patterns of hedgehog signaling peptides in naturally acquired equine osteochondrosis,” Journal of Orthopaedic Research, vol. 23, no. 5, pp. 1152–1159, 2005. View at Publisher · View at Google Scholar · View at PubMed
  168. T. Aigner, M. Hemmel, D. Neureiter et al., “Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritic human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage,” Arthritis and Rheumatism, vol. 44, no. 6, pp. 1304–1312, 2001. View at Publisher · View at Google Scholar
  169. K. Kühn, D. D. D'Lima, S. Hashimoto, and M. Lotz, “Cell death in cartilage,” Osteoarthritis and Cartilage, vol. 12, no. 1, pp. 1–16, 2004. View at Publisher · View at Google Scholar
  170. H. Dumond, N. Presle, P. Pottie et al., “Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis,” Osteoarthritis and Cartilage, vol. 12, no. 4, pp. 284–295, 2004. View at Publisher · View at Google Scholar · View at PubMed
  171. J. C. Fernandes, J. Martel-Pelletier, V. Lascau-Coman et al., “Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study,” Journal of Rheumatology, vol. 25, no. 8, pp. 1585–1594, 1998.
  172. E. V. Tchetina, M. Kobayashi, T. Yasuda, T. Meijers, I. Pidoux, and A. R. Poole, “Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis,” Matrix Biology, vol. 26, no. 4, pp. 247–258, 2007. View at Publisher · View at Google Scholar · View at PubMed
  173. H. Lorenz, W. Wenz, M. Ivancic, E. Steck, and W. Richter, “Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading,” Arthritis Research & Therapy, vol. 7, no. 1, pp. R156–R165, 2005.
  174. J. R. Matyas, P. F. Ehlers, D. Huang, and M. E. Adams, “The early molecular natural history of experimental osteoarthritis: I. Progressive discoordinate expression of aggrecan and type II procollagen messenger rna in the articular cartilage of adult animals,” Arthritis and Rheumatism, vol. 42, no. 5, pp. 993–1002, 1999. View at Publisher · View at Google Scholar
  175. J. R. Matyas, D. Huang, M. Chung, and M. E. Adams, “Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis,” Arthritis and Rheumatism, vol. 46, no. 6, pp. 1536–1543, 2002. View at Publisher · View at Google Scholar · View at PubMed
  176. C. T. G. Appleton, D. D. McErlain, V. Pitelka et al., “Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis,” Arthritis Research & Therapy, vol. 9, article R13, 2007. View at Publisher · View at Google Scholar · View at PubMed
  177. F. Moldovan, J. Pelletier, F. C. Jolicoeur, J. M. Cloutier, and J. Martel-Pelletier, “Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage,” Osteoarthritis and Cartilage, vol. 8, no. 3, pp. 186–196, 2000. View at Publisher · View at Google Scholar · View at PubMed
  178. B. Rolauffs, J. M. Williams, M. Aurich, A. J. Grodzinsky, K. E. Kuettner, and A. A. Cole, “Proliferative remodeling of the spatial organization of human superficial chondrocytes distant from focal early osteoarthritis,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 489–498, 2010. View at Publisher · View at Google Scholar · View at PubMed
  179. N. Miosge, M. Hartmann, C. Maelicke, and R. Herken, “Expression of collagen type I and type II in consecutive stages of human osteoarthritis,” Histochemistry and Cell Biology, vol. 122, no. 3, pp. 229–236, 2004. View at Publisher · View at Google Scholar · View at PubMed
  180. A. P. Hollander, I. Pidoux, A. Reiner, C. Rorabeck, R. Bourne, and A. R. Poole, “Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration,” Journal of Clinical Investigation, vol. 96, no. 6, pp. 2859–2869, 1995.
  181. A. R. Poole, M. Alini, and A. P. Hollander, “Cellular biology of cartilage degradation,” in Mechanisms and Models in Rheumatoid Arthritis, pp. 163–203, Academic Press, London, UK, 1995.
  182. T. Aigner, A. Zien, A. Gehrsitz, P. M. Gebhard, and L. McKenna, “Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology,” Arthritis and Rheumatism, vol. 44, no. 12, pp. 2777–2789, 2001. View at Publisher · View at Google Scholar
  183. M. Gebauer, J. Saas, J. Haag et al., “Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage,” Arthritis Research & Therapy, vol. 7, no. 2, pp. R274–R284, 2005.
  184. A. C. Bay-Jensen, T. L. Andersen, N. Charni-Ben Tabassi et al., “Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage,” Osteoarthritis and Cartilage, vol. 16, no. 5, pp. 615–623, 2008. View at Publisher · View at Google Scholar · View at PubMed
  185. D. Pfander, R. Rahmanzadeh, and E. E. Scheller, “Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage,” Journal of Rheumatology, vol. 26, no. 2, pp. 386–394, 1999.
  186. K. Veje, J. L. Hyllested-Winge, and K. Ostergaard, “Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis,” Osteoarthritis and Cartilage, vol. 11, no. 3, pp. 217–227, 2003. View at Publisher · View at Google Scholar
  187. H. Lorenz and W. Richter, “Osteoarthritis: cellular and molecular changes in degenerating cartilage,” Progress in Histochemistry and Cytochemistry, vol. 40, no. 3, pp. 135–163, 2006. View at Publisher · View at Google Scholar · View at PubMed
  188. E. N. Blaney Davidson, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg, “Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation,” Annals of the Rheumatic Diseases, vol. 65, no. 11, pp. 1414–1421, 2006. View at Publisher · View at Google Scholar · View at PubMed
  189. N. Yatsugi, T. Tsukazaki, M. Osaki, T. Koji, S. Yamashita, and H. Shindo, “Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc,” Journal of Orthopaedic Science, vol. 5, no. 2, pp. 150–156, 2000.
  190. P. Garnero, X. Ayral, J. C. Rousseau et al., “Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis,” Arthritis and Rheumatism, vol. 46, no. 10, pp. 2613–2624, 2002. View at Publisher · View at Google Scholar · View at PubMed
  191. E. Gómez-Barrena, O. Sánchez-Pernaute, R. Largo, E. Calvo, P. Esbrit, and G. Herrero-Beaumont, “Sequential changes of parathyroid hormone related protein (PTHrP) in articular cartilage during progression of inflammatory and degenerative arthritis,” Annals of the Rheumatic Diseases, vol. 63, no. 8, pp. 917–922, 2004. View at Publisher · View at Google Scholar · View at PubMed
  192. M. Pombo-Suarez, M. T. Castaño-Oreja, M. Calaza, J. Gomez-Reino, and A. Gonzalez, “Differential upregulation of the three transforming growth factor beta isoforms in human osteoarthritic cartilage,” Annals of the Rheumatic Diseases, vol. 68, no. 4, pp. 568–571, 2009. View at Publisher · View at Google Scholar · View at PubMed
  193. C. J. Brew, P. D. Clegg, R. P. Boot-Handford, J. G. Andrew, and T. Hardingham, “Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 234–240, 2010. View at Publisher · View at Google Scholar · View at PubMed
  194. T. Hayami, M. Pickarski, Y. Zhuo, G. A. Wesolowski, G. A. Rodan, and LE. T. Duong, “Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis,” Bone, vol. 38, no. 2, pp. 234–243, 2006. View at Publisher · View at Google Scholar · View at PubMed
  195. T. Pufe, W. Petersen, B. Tillmann, and R. Mentlein, “The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage,” Arthritis and Rheumatism, vol. 44, no. 5, pp. 1082–1088, 2001. View at Publisher · View at Google Scholar
  196. M. Sharif, J. Kirwan, N. Charni, L. J. Sandell, C. Whittles, and P. Garnero, “A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis—association with disease progression,” Rheumatology, vol. 46, no. 6, pp. 938–943, 2007. View at Publisher · View at Google Scholar · View at PubMed
  197. E. V. Tchetina, J. Antoniou, M. Tanzer, D. J. Zukor, and A. R. Poole, “Transforming growth factor-β2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E2 production,” American Journal of Pathology, vol. 168, no. 1, pp. 131–140, 2006. View at Publisher · View at Google Scholar
  198. W. Hui, T. Cawston, and A. D. Rowan, “Transforming growth factor β1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor α from bovine cartilage,” Annals of the Rheumatic Diseases, vol. 62, no. 2, pp. 172–174, 2003. View at Publisher · View at Google Scholar
  199. J. Jiang, N. L. Leong, J. C. Mung, C. Hidaka, and H. H. Lu, “Interaction between zonal populations of articular chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP,” Osteoarthritis and Cartilage, vol. 16, no. 1, pp. 70–82, 2008. View at Publisher · View at Google Scholar · View at PubMed
  200. W. Kafienah, S. Mistry, S. C. Dickinson, T. J. Sims, I. Learmonth, and A. P. Hollander, “Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients,” Arthritis and Rheumatism, vol. 56, no. 1, pp. 177–187, 2007. View at Publisher · View at Google Scholar · View at PubMed
  201. E. V. Tchetina, J. A. Di Battista, D. J. Zukor, J. Antoniou, and A. R. Poole, “Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy,” Arthritis Research & Therapy, vol. 9, no. 4, p. R75, 2007. View at Publisher · View at Google Scholar · View at PubMed
  202. J. Akaogi, T. Nozaki, M. Satoh, and H. Yamada, “Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy,” Endocrine, Metabolic & Immune Disorders-Drug Targets, vol. 6, no. 4, pp. 383–394, 2006.
  203. M. Attur, H. E. Al-Mussawir, J. Patel et al., “Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor,” Journal of Immunology, vol. 181, no. 7, pp. 5082–5088, 2008.
  204. D. D'Lima, J. Hermida, S. Hashimoto, C. Colwell, and M. Lotz, “Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis,” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1814–1821, 2006. View at Publisher · View at Google Scholar · View at PubMed
  205. A. Scharstuhl, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg, “Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor β/bone morphogenetic protein inhibitors during experimental osteoarthritis,” Arthritis and Rheumatism, vol. 48, no. 12, pp. 3442–3451, 2003. View at Publisher · View at Google Scholar · View at PubMed
  206. A. C. Lin, B. L. Seeto, J. M. Bartoszko et al., “Modulating hedgehog signaling can attenuate the severity of osteoarthritis,” Nature Medicine, vol. 15, no. 12, pp. 1421–1425, 2009. View at Publisher · View at Google Scholar · View at PubMed
  207. E. Araldi and E. Schipani, “MicroRNA-140 and the silencing of osteoarthritis,” Genes and Development, vol. 24, no. 11, pp. 1075–1080, 2010. View at Publisher · View at Google Scholar · View at PubMed
  208. S. S. Glasson, R. Askew, B. Sheppard et al., “Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis,” Nature, vol. 434, no. 7033, pp. 644–648, 2005. View at Publisher · View at Google Scholar · View at PubMed
  209. S. Kamekura, Y. Kawasaki, K. Hoshi et al., “Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2462–2470, 2006. View at Publisher · View at Google Scholar · View at PubMed
  210. A. R. Klatt, G. Klinger, O. Neumüller et al., “TAK1 downregulation reduces IL-1β induced expression of MMP13, MMP1 and TNF-alpha,” Biomedicine and Pharmacotherapy, vol. 60, no. 2, pp. 55–61, 2006. View at Publisher · View at Google Scholar · View at PubMed
  211. J. Weisser, B. Rahfoth, A. Timmermann, T. Aigner, R. Bräuer, and K. von der Mark, “Role of growth factors in rabbit articular cartilage repair by chondrocytes in agarose,” Osteoarthritis and Cartilage, vol. 9, pp. S48–S54, 2001. View at Publisher · View at Google Scholar
  212. T. Yamamoto, S. Wakitani, K. Imoto et al., “Fibroblast growth factor-2 promotes the repair of partial thickness defects of articular cartilage in immature rabbits but not in mature rabbits,” Osteoarthritis and Cartilage, vol. 12, no. 8, pp. 636–641, 2004. View at Publisher · View at Google Scholar · View at PubMed
  213. P. R. Elford, M. Graeber, H. Ohtsu et al., “Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor β-2 in the rabbit,” Cytokine, vol. 4, no. 3, pp. 232–238, 1992.
  214. S. B. Trippel, “Growth factor inhibition: potential role in the etiopathogenesis of osteoarthritis,” Clinical Orthopaedics and Related Research, no. 427, pp. S47–S52, 2004. View at Publisher · View at Google Scholar
  215. J. I. Shida, S. Jingushi, T. Izumi, T. Ikenoue, and Y. Iwamoto, “Basic fibroblast growth factor regulates expression of growth factors in rat epiphyseal chondrocytes,” Journal of Orthopaedic Research, vol. 19, no. 2, pp. 259–264, 2001. View at Publisher · View at Google Scholar · View at PubMed
  216. P. C. Yaeger, T. L. Masi, J. L. Buck de Ortiz, F. Binette, R. Tubo, and J. M. McPherson, “Synergistic action of transforming growth factor-β and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes,” Experimental Cell Research, vol. 237, no. 2, pp. 318–325, 1997. View at Publisher · View at Google Scholar · View at PubMed
  217. A. Barbero, S. Grogan, D. Schäfer, M. Heberer, P. Mainil-Varlet, and I. Martin, “Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity,” Osteoarthritis and Cartilage, vol. 12, no. 6, pp. 476–484, 2004. View at Publisher · View at Google Scholar · View at PubMed
  218. A. V. Babarina, U. Möllers, K. Bittner, P. Vischer, and P. Bruckner, “Role of the subchondral vascular system in endochondral ossification: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro,” Matrix Biology, vol. 20, no. 3, pp. 205–213, 2001. View at Publisher · View at Google Scholar
  219. J. O. P. Cheung, M. C. Hillarby, S. Ayad et al., “A novel cell culture model of chondrocyte differentiation during mammalian endochondral ossification,” Journal of Bone and Mineral Research, vol. 16, no. 2, pp. 309–318, 2001.
  220. M. J. Zuscik, J. F. Baden, Q. Wu et al., “5-azacytidine alters TGF-β and BMP signaling and induces maturation in articular chondrocytes,” Journal of Cellular Biochemistry, vol. 92, no. 2, pp. 316–331, 2004. View at Publisher · View at Google Scholar · View at PubMed
  221. M. L. Ho, JE. K. Chang, S. C. Wu et al., “A novel terminal differentiation model of human articular chondrocytes in three-dimensional cultures mimicking chondrocytic changes in osteoarthritis,” Cell Biology International, vol. 30, no. 3, pp. 288–294, 2006. View at Publisher · View at Google Scholar · View at PubMed
  222. T. Yasuda, E. Tchetina, K. Ohsawa et al., “Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage,” Matrix Biology, vol. 25, no. 7, pp. 419–429, 2006. View at Publisher · View at Google Scholar · View at PubMed
  223. T. Yasuda and A. R. Poole, “A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway,” Arthritis and Rheumatism, vol. 46, no. 1, pp. 138–148, 2002. View at Publisher · View at Google Scholar
  224. G. A. Homandberg, “Cartilage damage by matrix degradation products: fibronectin fragments,” Clinical Orthopaedics and Related Research, no. 391, pp. S100–S107, 2001.
  225. R. Serra, M. Johnson, E. H. Filvaroff et al., “Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis,” Journal of Cell Biology, vol. 139, no. 2, pp. 541–552, 1997. View at Publisher · View at Google Scholar
  226. T. F. Li, M. Darowish, M. J. Zuscik et al., “Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation,” Journal of Bone and Mineral Research, vol. 21, no. 1, pp. 4–16, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  227. G. Valverde-Franco, J. S. Binette, . et al., “Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice,” Human Molecular Genetics, vol. 15, no. 11, pp. 1783–1792, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  228. C. T. G. Appleton, S. E. Usmani, S. M. Bernier, T. Aigner, and F. Beier, “Transforming growth factor α suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis,” Arthritis and Rheumatism, vol. 56, no. 11, pp. 3693–3705, 2007. View at Publisher · View at Google Scholar · View at PubMed
  229. M. B. Goldring and K. B. Marcu, “Cartilage homeostasis in health and rheumatic diseases,” Arthritis Research & Therapy, vol. 11, no. 3, article 224, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  230. D. L. Cecil, K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub, “Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products,” Journal of Immunology, vol. 175, no. 12, pp. 8296–8302, 2005. View at Scopus
  231. D. Merz, R. Liu, K. Johnson, and R. Terkeltaub, “IL-8/CXCl8 and growth-related oncogene α/CXCL1 induce chondrocyte hypertrophic differentiation,” Journal of Immunology, vol. 171, no. 8, pp. 4406–4415, 2003. View at Scopus
  232. C. Baugé, F. Legendre, S. Leclercq et al., “Interleukin-1β impairment of transforming growth factor β1 signaling by down-regulation of transforming growth factor β receptor type II and up-regulation of Smad7 in human articular chondrocytes,” Arthritis and Rheumatism, vol. 56, no. 9, pp. 3020–3032, 2007. View at Publisher · View at Google Scholar · View at PubMed